Early detection of myocardial dysfunction in children with mitochondrial disease: An ultrasound and two-dimensional strain echocardiography study

Mitochondrion

Volumn 11, Issue 3, 2011, Pages 405-412

  Marcus, Karen A ^a   Barends, Marlieke ^a   Morava Kozicz, Eva ^a   Feuth, Ton ^a   de Korte, Chris L ^a   Kapusta, Livia ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Schneider Children's Medical Centre of Israel   (Israel)

Author keywords

Cardiomyopathy; Child; Echocardiography; Mitochondrial disease; Two dimensional strain echocardiography

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; GENETIC ANALYSIS; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTERMETHOD COMPARISON; MALE; MYOCARDIAL DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INFANT; MALE; MITOCHONDRIAL DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 79953730566     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2010.12.005     Document Type: Article

References (42)

1. Amundsen B.H., Helle-Valle T., Edvardsen T., Torp H., Crosby J., Lyseggen E., Støylen A., Ihlen H., Slørdahl S.A. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J. Am. Coll. Cardiol. 2006, 47(4):789-793.
2. Aurigemma G.P., Silver K.H., Priest M.A., Gaasch W.H. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J. Am. Coll. Cardiol. 1995, 26(1):195-202.
3. Bauer F., Mghaieth F., Dervaux N., Donal E., Derumeaux G., Cribier A., Bessou J.P. Preoperative tissue Doppler imaging differentiates beneficial from detrimental left ventricular hypertrophy in patients with surgical aortic stenosis. A postoperative morbidity study. Heart 2008, 94(11):440-445.
4. Berne R.M., Levy M.N. Physiology, ed 3. St Louis: Mosby 1993.
5. Cerqueira M.D., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., Pennell D.J., Rumberger J.A., Ryan T., Verani M.S. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int. J. Cardiovasc. Imaging 2002, 18(1):539-542.
6. Cízková A., Stráneckỳ V., Mayr J.A., Tesarová M., Havlícková V., Paul J., Ivánek R., Kuss A.W., Hansíková H., Kaplanová V., Vrbackỳ M., Hartmannová H., Nosková L., Honzík T., Drahota Z., Magner M., Hejzlarová K., Sperl W., Zeman J., Houstek J., Kmoch S. TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathy. Nat. Genet. 2008, 40(11):1288-1290.
7. Colan S.D., Borow K.M., Neumann A. Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. J. Am. Coll. Cardiol. 1984, 4(4):715-724.
8. Dandel M., Hetzer R. Echocardiographic strain and strain rate imaging - clinical applications. Int. J. Cardiol. 2009, 132(1):11-24.
9. Darin N., Oldfors A., Moslemi A.R., Holme E., Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. Ann. Neurol. 2001, 49(3):377-383.
10. Debray F.G., Lambert M., Chevalier I., Robitaille Y., Decarie J.C., Shoubridge E.A., Robinson B.H., Mitchell G.A. Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases. Pediatrics 2007, 119(4):722-733.
11. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977, 55(4):613-618.
12. DiMauro S., Schon E.A. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 2003, 348(26):2656-2668.
13. Esposito L.A., Melov S., Panov A., Cottrell B.A., Wallace D.C. Mitochondrial disease in mouse results in increased oxidative stress. Proc. Natl Acad. Sci. USA 1999, 96(9):4820-4825.
14. Friedberg M.K., Slorach C. Relation between left ventricular regional radial function and radial wall motion abnormalities using two-dimensional speckle tracking in children with idiopathic dilated cardiomyopathy. Am. J. Cardiol. 2008, 102(3):335-339.
15. Guenthard J., Wyler F., Fowler B., Baumgartner R. Cardiomyopathy in respiratory chain disorders. Arch. Dis. Child. 1995, 72(3):223-226.
16. Hansson A., Hance N., Dufour E., Rantanen A., Hultenby K., Clayton D.A., Wibom R., Larsson N.G. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc. Natl Acad. Sci. USA 2004, 101(9):3136-3141.
17. Ho E., Brown A., Barret P., Morgan R.B., King G., Kennedy M.J., Murphy R.T. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart 2010, 96(9):701-707.
18. Holmgren D., Wåhlander H., Eriksson B.O., Oldfors A., Holme E., Tulinius M. Cardiomyopathy in children with mitochondrial disease: clinical course and cardiological findings. Eur. Heart J. 2003, 24(3):280-288.
19. Janssen A.J., Trijbels F.J., Sengers R.C., Wintjes L.T., Ruitenbeek W., Smeitink J.A., Morava E., van Engelen B.G., van den Heuvel L.P., Rodenburg R.J. Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology. Clin. Chem. 2006, 52(5):860-871.
20. Johns D.R. Mitochondrial DNA and disease. N. Engl. J. Med. 1995, 333:638-644.
21. Khoury P.R., Mitsnefes M., Daniels S.R., Kimball T.R. Age-specific reference intervals for indexed left ventricular mass in children. J. Am. Soc. Echocardiogr. 2009, 22(6):709-714.
22. Lafitte S., Perlant M., Reant P., Serri K., Douard H., DeMaria A., Roudaut R. Impact of impaired myocardial deformations on exercise tolerance and prognosis in patients with asymptomatic aortic stenosis. Eur. J. Echocardiogr. 2009, 10(3):414-419.
23. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., Stewart W.J. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 2005, 18(12):1440-1463. Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines and Standards CommitteeAmerican Society of Echocardiography's Guidelines and Standards Committee, European Association of EchocardiographyEuropean Association of Echocardiography.
24. Leitman M., Lysyansky P., Sidenko S., Shir V., Peleg E., Binenbaum M., Kaluski E., Krakover R., Vered Z. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J. Am. Soc. Echocardiogr. 2004, 17(10):1021-1029.
25. Lev D., Nissenkorn A., Leshinsky-Silver E., Sadeh M., Zeharia A., Garty B.Z., Blieden L., Barash V., Lerman-Sagie T. Clinical presentations of mitochondrial cardiomyopathies. Pediatr. Cardiol. 2004, 25(5):443-450.
26. Mavinkurve-Groothuis A.M.C., Weijers G., Groot-Loonen J., Pourier M.S., Feuth T., de Korte C.L., Hoogerbrugge P.M., Kapusta L. Interobserver, intraobserver and intrapatient reliability scores of myocardial strain imaging with two-dimensional echocardiography in patients treated with anthracyclines. Ultrasound Med. Biol. 2009, 35(4):697-704.
27. Morava E., van den Heuvel L., Hol F., de Vries M.C., Hogeveen M., Rodenburg R.J., Smeitink J.A. Mitochondrial disease criteria: diagnostic applications in children. Neurology 2006, 67(10):1823-1826.
28. Ng A.C., Delgado V., Bertini M., van der Meer R.W., Rijzewijk L.J., Shanks M., Nucifora G., Smit J.W., Diamant M., Romijn J.A., de Roos A., Leung D.Y., Lamb H.J., Bax J.J. Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type-2 diabetes mellitus. Am. J. Cardiol. 2009, 104(10):1398-1401.
29. Nissenkorn A., Zeharia A., Lev D., Fatal-Valevski A., Barash V., Gutman A., Harel S., Lerman-Sagie T. Multiple presentation of mitochondrial disorders. Arch. Dis. Child. 1999, 81(3):209-214.
30. Petty R.K., Harding A.E., Morgan-Hughes J.A. The clinical features of mitochondrial myopathy. Brain 1986, 109(5):915-938.
31. Rowland D.G., Gutgesell H.P. Use of mean arterial pressure for noninvasive determination of left ventricular end-systolic wall stress in infants and children. Am. J. Cardiol. 1994, 74(1):98-99.
32. Sato W., Tanaka M., Sugiyama S., Nemoto T., Harada K., Miura Y., Kobayashi Y., Goto A., Takada G., Ozawa T. cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Am. Heart J. 1994, 128(4):733-741.
33. Scaglia F., Towbin J.A., Craigen W.J., Belmont J.W., Smith E.O., Neish S.R., Ware S.M., Hunter J.V., Fernbach S.D., Vladutiu G.D., Wong L.J., Vogel H. Clinical spectrum, morbidity, and mortality in 113 patients with mitochondrial disease. Pediatrics 2004, 114(4):925-931.
34. Sebastiani M., Giordano C., Nediani C., Travaglini C., Borchi E., Zani M., Feccia M., Mancini M., Petrozza V., Cossarizza A., Gallo P., Taylor R.W., d'Amati G. Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies. Am. Coll. Cardiol. 2007, 50(14):1362-1369.
35. Smeitink J., van den Heuvel L., DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat. Rev. Genet. 2001, 2(5):342-352.
36. Smeitink J.A., Zeviani M., Turnbull D.M., Jacobs H.T. Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab. 2006, 3(1):9-13.
37. Tei C., Ling L.H., Hodge D.O., Bailey K.R., Oh J.K., Rodeheffer R.J., Tajik A.J., Seward J.B. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyoapathy. J. Cardiol. 1995, 26(6):357-366.
38. Wallace D. Diseases of mitochondrial DNA. Annu. Rev. Biochem. 1992, 61:1175-1212.
39. Ware S.M., El-Hassan N., Kahler S.G., Zhang Q., Ma Y.W., Miller E., Wong B., Spicer R.L., Craigen W.J., Kozel B.A., Grange D.K., Wong L.J. Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes. J. Med. Genet. 2009, 46(5):308-314.
40. Wolf N.I., Smeitink J.A. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 2002, 59(9):1402-1405.
41. Wortmann S.B., Rodenburg R.J., Jonckheere A., de Vries M.C., Huizing M., Heldt K., van den Heuvel L.P., Wendel U., Kluijtmans L.A., Engelke U.F., Wevers R.A., Smeitink J.A., Morava E. Biochemical and genetic analysis of 3-methylglutaconic aciduria type IV: a diagnostic strategy. Brain 2009, 132(1):136-146.
42. Yaplito-Lee J., Weintraub R., Jamsen K., Chow C.W., Thorburn D.R., Boneh A. Cardiac manifestations in oxidative phosphorylation disorders of childhood. J. Pediatr. 2007, 150(4):407-411.